Document Detail


Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers.
MedLine Citation:
PMID:  3184779     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The trans-isomer of 3'-hydroxycotinine has recently been identified as a major metabolite of nicotine in urine of cigarette smokers. We, therefore, investigated the pharmacokinetics of 3'-hydroxycotinine in six male smokers after intravenous infusion of nicotine, cotinine, and 3'-hydroxycotinine. Serum concentrations of 3'-hydroxycotinine were lower than those of cotinine throughout the observation period of 60 h after infusion of nicotine or cotinine, whereas the amounts excreted in the urine were similar or higher than those of cotinine. The following means and ranges for the pharmacokinetic parameters were derived from the 3'-hydroxycotinine infusion experiment: half-life (t1/2 beta) = 5.9 (4.2-9.5) h; apparent volume of distribution (Vd) = 0.87 (0.51-1.14) l/kg; total clearance (Cl total) = 1.79 (1.08-2.59) ml/min/kg; renal clearance (Clr) = 1.31 (0.85-1.78) ml/min/kg; percentage of renal clearance (Clr/Cl total) = 75.4 +/- 12.8 (60.3-98.2). The high percentage of renal clearance suggests that further metabolization of this compound is limited. No evidence for a mutagenic activity of 3'-hydroxycotinine or of urine extracts from subjects dosed with hydroxycotinine was found with the S. typhimurium (TA 98) microsome assay.
Authors:
G Scherer; L Jarczyk; W D Heller; A Biber; G B Neurath; F Adlkofer
Related Documents :
6657719 - Control of behavior by intravenous nicotine injections in laboratory animals.
15008689 - Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heav...
24502679 - A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as pr...
2498949 - Chronic and acute tolerance to the heart rate effects of nicotine.
24120259 - Personalized tacrolimus doses determined by cyp3a5 genotype for induction and maintenan...
23755309 - Safety, pharmacokinetic, and efficacy studies of oral db868 in a first stage vervet mon...
1145769 - The significance of the tuberculin test using bioequivalent ppd.
21879809 - Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed ...
2511749 - Effect of traditional herbal medicine, shakuyaku-kanzo-to on total and free serum testo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Klinische Wochenschrift     Volume:  66 Suppl 11     ISSN:  0023-2173     ISO Abbreviation:  Klin. Wochenschr.     Publication Date:  1988  
Date Detail:
Created Date:  1988-12-21     Completed Date:  1988-12-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985205R     Medline TA:  Klin Wochenschr     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  5-11     Citation Subset:  IM    
Affiliation:
Forschungsgesellschaft Rauchen und Gesundheit mbH, Hamburg.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cotinine / administration & dosage,  analogs & derivatives,  pharmacokinetics*
Humans
Infusions, Intravenous
Male
Metabolic Clearance Rate
Mutagenicity Tests
Nicotine / administration & dosage,  pharmacokinetics*
Pyrrolidinones / pharmacokinetics*
Smoking / blood*
Chemical
Reg. No./Substance:
0/Pyrrolidinones; 27323-64-4/hydroxycotinine; 486-56-6/Cotinine; 54-11-5/Nicotine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood platelet function after chronic treatment of rats and guinea pigs with nicotine.
Next Document:  The Eberbach/Wiesloch Study: lipoprotein profiles of 35- to 49-year-old men and women.